May 30, 2020

The Niche

Knoepfler lab stem cell blog

first stem cell drug

1 min read

Adult stem cell biotech Mesoblast ($MESO) is in the unusual situation currently of having its stock on hold. This is a relatively rare event and usually portends some kind of major news. The hold is expected to run from June 1 to June 10. Mesoblast will announce ““material corporate developments with respect to certain assets of the company”. This could involve good or bad news related to one of several partnerships or some other development. In late 2015 Mesoblast had upbeat news of a …Read More